Segments - Operations and Assets Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jan. 01, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Total revenues	$ 179,744	$ 385,813	$ 818,856	$ 1,373,387
Operating income (loss)	(87,820)	37,826	(170,984)	81,834
Depreciation and amortization	27,995	18,963	82,195	59,525
Loss from investment in investees	(43)	(53)	(359)	(163)
Assets	2,224,785		2,224,785			$ 2,399,715
Goodwill	573,499		573,499		$ 710,408	520,601
United States
Segment Reporting Information [Line Items]
Total revenues	149,841	354,586	634,754	1,269,749
Ireland
Segment Reporting Information [Line Items]
Total revenues	6,680	5,445	104,318	24,663
Chile
Segment Reporting Information [Line Items]
Total revenues	14,347	16,486	46,490	49,294
Spain
Segment Reporting Information [Line Items]
Total revenues	4,564	5,721	17,370	17,077
Israel
Segment Reporting Information [Line Items]
Total revenues	251	307	3,663	3,543
Mexico
Segment Reporting Information [Line Items]
Total revenues	3,886	3,162	11,691	8,619
Other
Segment Reporting Information [Line Items]
Total revenues	174	106	570	442
Corporate
Segment Reporting Information [Line Items]
Operating income (loss)	(10,068)	(10,457)	(29,467)	(30,585)
Depreciation and amortization	0	0	0	0
Loss from investment in investees	0	0	0	0
Assets	230,320		230,320			46,672
Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	(28,298)	28,625	9,020	(4,251)
Depreciation and amortization	17,840	6,080	50,882	20,500
Loss from investment in investees	(43)	(53)	(359)	(163)
Assets	1,297,347		1,297,347			1,114,460
Goodwill	290,474		290,474			237,576
Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Operating income (loss)	(49,454)	19,658	(150,537)	116,670
Depreciation and amortization	10,155	12,883	31,313	39,025
Loss from investment in investees	0	0	0	0
Assets	697,118		697,118			1,238,583
Goodwill	283,025		283,025			$ 283,025
Services
Segment Reporting Information [Line Items]
Total revenues	142,856	340,163	616,259	1,244,312
Services | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0	0	0
Services | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	0	0	0	0
Services | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	142,856	340,163	616,259	1,244,312
Products
Segment Reporting Information [Line Items]
Total revenues	32,388	36,882	104,938	106,490
Products | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0	0	0
Products | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	32,388	36,882	104,938	106,490
Products | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	0	0	0	0
Transfer of intellectual property and other
Segment Reporting Information [Line Items]
Total revenues	4,500	8,768	97,659	22,585
Transfer of intellectual property and other | Corporate
Segment Reporting Information [Line Items]
Total revenues	0	0	0	0
Transfer of intellectual property and other | Pharmaceutical | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	4,500	8,768	97,659	22,585
Transfer of intellectual property and other | Diagnostics | Operating Segments
Segment Reporting Information [Line Items]
Total revenues	$ 0	$ 0	$ 0	$ 0